ESPERITE (ESP) expects publication of Annual Report 2017 before 17 November 2018
09 nov. 2018 01h17 HE
|
Esperite N.V.
Amsterdam, The Netherlands - 09 November 2018 Esperite announces that the preparation of its Annual Report 2017 is nearly finalized and expects the publication of its Annual Report 2017 before...
Esperite Group with The Cell Factory, expands its patent portfolio on extra-cellular vesicles biologic drugs in Canada.
07 nov. 2018 01h17 HE
|
Esperite N.V.
Amsterdam, the Netherlands - 7 November 2018 Esperite's (Euronext: ESP) biotech company The Cell Factory has obtained the patent for the use of extracellular vesicles (EVs) in the treatment of...
Esperite Group with The Cell Factory expands its Extracellular Vesicles product portfolio of anti-inflammatory drugs with a fourth indication : Bronchopulmonary Dysplasia.
06 nov. 2018 02h55 HE
|
Esperite N.V.
Amsterdam, the Netherlands - 6 November 2018 The Cell Factory in collaboration with the University of Padova, Italy has completed pre-clinical in-vivo tests of the CF-MEV-132 drug candidate for...
ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 22nd tranche of investment today
15 oct. 2018 01h17 HE
|
Esperite N.V.
Amsterdam, The Netherlands - 15 October 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a 22nd Tranche of EUR 400,000 is issued as a private placement of 40...
Esperite N.V. (ESP): Sale by Esperite of stake in Cryo-Save South Africa cancelled
03 oct. 2018 12h18 HE
|
Esperite N.V.
Amsterdam, The Netherlands - 3 October 2018 Esperite N.V. (Euronext: ESP, the "Company" or "Esperite") today announced that the sale agreement between Esperite and Go-Life Healthcare Limited...
ESPERITE N.V. (ESP) WITH CRYOSAVE READY TO STORE MORE THAN A MILLION SAMPLES IN ITS NEW DESIGNED CRYOSTORAGE FACILITY IN GENEVA.
13 sept. 2018 01h17 HE
|
Esperite N.V.
CryoSave has fully equipped this new safe and secure sample storage BioBank in its state-of-the-art central laboratory in Geneva, Switzerland especially designed for optimal cryopreservation of...
Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2017.
31 août 2018 01h17 HE
|
Esperite N.V.
Amsterdam, The Netherlands - 31 August 2018 Esperite NV announced mid-August that the Company had solved the technical issues that caused the delay regarding the publication of the Annual Report...
ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 21st tranche of investment today
29 août 2018 01h17 HE
|
Esperite N.V.
Amsterdam, The Netherlands - 29 August 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a 21st Tranche of EUR 300,000 is issued as a private placement of 30...
Esperite N.V. (ESP) : Update on the publication of the Annual Report 2017.
15 août 2018 01h17 HE
|
Esperite N.V.
Amsterdam, The Netherlands - 15 August 2018 Esperite NV announces having solved the technical issues that caused the delay regarding the publication of the Annual Report 2017. The departments...
Esperite N.V. (ESP) : Additional delays needed on the publication of the Annual Report 2017
18 juil. 2018 02h26 HE
|
Esperite N.V.
Amsterdam, The Netherlands - 18 July 2018 Following earlier information provided regarding the delay on the publication of the Annual Report 2017 mainly due to technical issues which have now...